~~____________________~~

(in Millions)

Guarantees:

Guarantees of vendor financing - short term (1)

$	140.6

~~(1)~~ Other debt guarantees (2)		Represents guarantees to financial institutions on behalf of certain FMC Agricultural Solutions customers for their seasonal borrowing. The short-term amount is recorded on the consolidated balance sheets as “Guarantees of vendor financing.” The long-term amount is recorded on the consolidated balance sheets within “Other long-term liabilities.”

0
~~(2)~~Total			These guarantees represent support provided to third-party banks for credit extended to various FMC Agricultural Solutions customers and nonconsolidated affiliates. The liability for the guarantees is recorded at an amount that approximates fair value (i.e. representing the stand-ready obligation) based on our historical collection experience and a current assessment of credit exposure. We believe the fair value of these guarantees is immaterial. The majority of these guarantees have an expiration date of less than one year.$	140.6

____________________

(1)Represents guarantees to financial institutions on behalf of certain customers for their seasonal borrowing. The short-term amount is recorded as "Guarantees of vendor financing" on the consolidated balance sheets.

(2)These guarantees represent support provided to third-party banks for credit extended to various customers and nonconsolidated affiliates. The liability for the guarantees is recorded at an amount that approximates fair value (i.e. representing the stand-ready obligation) based on our historical collection experience and a current assessment of credit exposure. In the past, the fair value of these guarantees has been immaterial and the majority of these guarantees have had an expiration date of less than one year.

Excluded from the chart above are ~~parent company~~parent-company guarantees we provide to lending institutions that extend credit to our foreign subsidiaries. Since these guarantees are provided for consolidated subsidiaries, the consolidated financial position is not affected by the issuance of these guarantees. Also excluded from the chart, in connection with our property and asset sales and divestitures, we have agreed to indemnify the ~~buyers~~buyer for certain liabilities, including environmental contamination and taxes that occurred prior to the date of sale or provided guarantees to third parties relating to certain contracts assumed by the buyer. Our indemnification or guarantee obligations with respect to ~~these~~certain liabilities may be indefinite as to duration and may or may not be subject to a deductible, minimum claim amount or cap. As such, it is not possible for us to predict the likelihood that a claim will be made or to make a reasonable estimate of the maximum potential loss or range of loss. If triggered, we may be able to recover some of the indemnity payments from third parties. WeTherefore, we have not recorded any specific liabilities for these guarantees. For certain obligations related to our divestitures for which we can make a reasonable estimate of the maximum potential loss or range of loss and is probable, a liability in those instances has been recorded.

Commitments

~~Leases~~

We lease office space, plants and facilities, and various types of manufacturing, data processing and transportation equipment. Leases of real estate generally provide for our payment of property taxes, insurance and repairs. Our capital leases primarily relate to two of our research and technology centers in the U.S. and China. Our capital lease asset balances (net of accumulated amortization of $2.3 million and $1.8 million), which are classified as buildings within our property, plant and equipment on our consolidated balance sheets, were $16.4 million and $16.9 million as of December 31, 2017 and 2016, respectively. Amortization of capital lease assets is included within depreciation expense. See Note 20 within these consolidated financial statements for obligations associated with our capital leases.

Year ended December 31,
(in Millions) 2017 2016 2015
Operating leases rent expense $ 27.6
$ 21.2
$ 16.0

~~Table of Contents~~

~~FMC CORPORATION~~

~~Notes to Consolidated Financial Statements — (Continued)~~

Future Minimum Lease Payments
(in Millions)
Operating Leases
Capital Leases
2018 $25.5 $3.6
2019 $24.3 $3.7
2020 $22.5 $3.7
2021 $19.9 $3.9
2022 $19.4 $3.9
Thereafter $164.5 $34.4

Purchase Obligations

Our minimum commitments under our take-or-pay purchase obligations associated with the sourcing of materials and energy total approximately ~~$4.7~~$825 million. Since the majority of our minimum obligations under these contracts are over the life of the contract on a year-by-year basis, we are unable to determine the periods in which these obligations could be payable under these contracts. However, we intend to fulfill the obligations associated with these contracts through our purchases associated with the normal course of business.

101

Table of Contents

FMC CORPORATION

Notes to Consolidated Financial Statements — (Continued)

Contingencies

Livent Corporation class action. On May 13, 2019, purported stockholders of our former subsidiary Livent Corporation ("Livent") filed a putative class action complaint in the Pennsylvania Court of Common Pleas, Philadelphia County, in connection with Livent’s October 2018 initial public offering (the "Livent IPO"). The complaint in this case, Plymouth County Retirement Association v. Livent Corp., et al., named as defendants Livent, certain of its current and former executives and directors, FMC Corporation, and underwriters involved in the Livent IPO ("Defendants"). The complaint alleges generally that the offering documents for the Livent IPO failed to adequately disclose certain information related to Livent’s business and prospects. The complaint alleges violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and seeks unspecified damages and other relief on behalf of all persons and entities who purchased or otherwise acquired Livent common stock pursuant and/or traceable to the Livent IPO offering documents. On July 2, 2019, Defendants moved to stay the Plymouth County action, in favor of two similar putative class actions relating to the Livent IPO, in which FMC had not been named as a Defendant, which are pending in the United States District Court of the Eastern District of Pennsylvania. On July 18, 2019, a separate state action was filed against the same Defendants in the Pennsylvania Court of Common Pleas, Philadelphia County, Bizzaria v. Livent Corp., et al. On July 26, 2019, Plymouth County filed an amended complaint in its state court case. On September 23, 2019, the actions were consolidated under the caption In re Livent Corporation Securities Litigation, No. 190501229. On October 11, 2019, Defendants filed preliminary objections seeking to dismiss the case in its entirety. On October 22, 2019, the Court denied Defendants’ motion to stay the case, but granted a separate motion of the Defendants to stay all discovery. On June 29, 2020 the court overruled the preliminary objections filed by the Defendants and on July 29, 2020, Defendants filed a motion seeking permission to appeal the state court's order.

Separately, on October 18, 2019, purported stockholders of Livent amended a putative class action complaint filed in the U.S. District Court for the Eastern District of Pennsylvania, to add FMC Corporation as a defendant. The operative complaint in that case, Bisser Nikolov v. Livent Corp., et al. makes similar substantive allegations as the state court case, including alleged violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and seeks unspecified damages and other relief on behalf of all persons and entities who purchased or otherwise acquired Livent common stock pursuant and/or traceable to the Livent IPO offering documents. Pursuant to a stipulated scheduling order, Defendants filed a motion to dismiss the Nikolov case on November 18, 2019. Plaintiffs filed their opposition to the motion to dismiss on December 30, 2019. On July 2, 2020, the federal court granted the Defendants' motion to dismiss and dismissed the federal complaint in its entirety. On July 31, 2020, Plaintiffs filed a notice of appeal.

On October 28, 2020, Defendants entered into a stipulation of settlement with the state court plaintiffs in which Livent, on behalf of the Defendants, will pay $7.4 million to resolve all claims related to the IPO. On October 29, 2020, the state court plaintiffs filed a motion seeking preliminary approval of the settlement. The court entered a preliminary approval order and the final hearing is scheduled for April 15, 2021. If approved, the settlement would resolve all pending litigation relating to the IPO, including the claims in both the state and federal actions. All deadlines in the state and federal actions are currently stayed in light of the settlement. There is no financial impact to FMC as a result of the settlement. Livent has agreed to defend and indemnify FMC with regard to these cases. FMC is cooperating with Livent and other Defendants to defend the litigation.

Competition / antitrust litigation related to the discontinued FMC Peroxygens segment. We are subject to actions brought by private plaintiffs relating to alleged violations of European and Canadian competition and antitrust laws, as further described below.

European competition action. Multiple European purchasers of hydrogen peroxide who claim to have been harmed as a result of alleged violations of European competition law by hydrogen peroxide producers assigned their legal claims to a single entity formed by a law firm. The single entity then filed a lawsuit in Germany in March 2009 against European producers, including our wholly-owned Spanish subsidiary, ~~Foret. Initial defense briefs were filed in April 2010, and an initial hearing was held during the first quarter of 2011, at which time case management issues were discussed. At~~FMC Foret SA ("Foret"). Foret executed a ~~subsequent hearing in October 2011, the Court indicated that~~Settlement Agreement on December 14, 2020 wherein it ~~was considering seeking guidance from the European Court of Justice (“ECJ”) as~~agreed to whether the German courts have jurisdiction over these claims. After submission of written comments on this issue by the parties, on March 1, 2012, the judge announced that she would refer the jurisdictional issuespay a confidential settlement amount to the ~~ECJ, which she did~~plaintiffs on April 29, 2013. On May 21, 2015, the ECJ issued its decision, upholding the jurisdiction of the German court. The case is now back before the German judge. We filed a motion to dismiss the proceedings in September 2015. We do not anticipate a response by the court until the spring of 2018. Since the case is in the preliminary stages and is based on a novel procedure - namely the attempt to create a cross-border “class action” which is not a recognized proceeding under EU or German law - we are unable to develop a reasonable estimate of our potential exposure of loss at this time. We intend to vigorously defend this matter.

~~Canadian antitrust actions~~. In 2005, after public disclosures of the U.S. federal grand jury investigation into the hydrogen peroxide industry (which resulted in no charges brought against us) and the filing of various class actions in U.S. federal and state courts, which have all been settled, putative class actions against us and ~~five~~ ~~other major hydrogen peroxide producers were filed in provincial courts in Ontario, Quebec and British Columbia under the laws of Canada. The other~~ ~~five~~ ~~defendants have settled these claims for a total of approximately~~ ~~$20.6 million~~. On September 28, 2009, the Ontario Superior Court of Justice certified a class of direct and indirect purchasers of hydrogen peroxide from 1994 to 2005. Our motion for leave to appeal the class certification decision was denied in June 2010.December 17, 2020. The case was largely dormant while the Canadian Supreme Court considered, in different litigation, whether indirect purchasers may recover overcharges in antitrust actions. In October 2013 the Court ruled that such recovery is permissible. Thereafter, the plaintiffs' moved to dismiss certain downstream purchasers (those who purchased products that contain hydrogen peroxide or were made using hydrogen peroxide) from the case and to reduce the class period to November 1, 1998 throughwithdrawn on December 31, 2003 - thereby eliminating six of the eleven years of the originally certified class period. The Court has approved this request. Since the proceedings are in the preliminary stages with respect to the merits, we are unable to develop a reasonable estimate of our potential exposure of loss at this time. We intend to vigorously defend these matters.18, 2020.

~~Table of Contents~~

~~FMC CORPORATION~~

~~Notes to Consolidated Financial Statements — (Continued)~~

Asbestos claims. Like hundreds of other industrial companies, we have been named as one of many defendants in asbestos-related personal injury litigation. Most of these cases allege personal injury or death resulting from exposure to asbestos in premises of FMC or to asbestos-containing components installed in machinery or equipment manufactured or sold by discontinued operations.

We intend to continue managing these asbestos-related cases in accordance with our historical experience. We have established a reserve for this litigation within our discontinued operations and believe that any exposure of a loss in excess of the established reserve cannot be reasonably estimated. Our experience has been that the overall trends in asbestos litigation have changed over time. Over the last several years, we have seen changes in the jurisdictions where claims against FMC are being filed and changes in the mix of products named in the various claims. Because these claim trends have yet to form a predictable

102

Table of Contents

FMC CORPORATION

Notes to Consolidated Financial Statements — (Continued)

pattern, we are presently unable to reasonably estimate our asbestos liability with respect to claims that may be filed in the future.

Other contingent liabilities. In addition to the matters disclosed above, we have certain other contingent liabilities arising from litigation, claims, products we have sold, guarantees or warranties we have made, contracts we have entered into, indemnities we have provided, and other commitments or obligations incident to the ordinary course of business. In Brazil, we are subject to claims from various governmental agencies regarding alleged additional indirect (non-income) taxes or duties as well as product liability matters and labor cases related to our operations. These disputes take many years to resolve as the matters move through administrative or judicial courts. We have provided reserves for such Brazilian matters that we consider probable and for which a reasonable estimate of the obligation can be made in the amount of ~~$2.2~~$4.1 million and ~~$6.7~~$4.9 million as of December 31, ~~2017~~2020 and ~~2016,~~2019, respectively. The aggregate estimated reasonably possible loss contingencies related to such Brazilian matters exceed amounts accrued by approximately ~~$77.1~~$80 million at December 31, ~~2017.~~2020. This reasonably possible estimate is based upon information available as of the date of the filing and the actual future losses may be higher given the uncertainties regarding the ultimate decision by administrative or judicial authorities in Brazil. Regarding other contingencies arising from operations, some of these contingencies are known - for example pending product liability litigation or claims - but are so preliminary that the merits cannot be determined, or if more advanced, are not deemed material based on current knowledge. Some contingencies are unknown - for example, claims with respect to which we have no notice or claims which may arise in the future, resulting from products we have sold, guarantees or warranties we have made, or indemnities we have provided. Therefore, we are unable to develop a reasonable estimate of our potential exposure of loss for these contingencies, either individually or in the aggregate, at this time. Based on information currently available and established reserves, we have no reason to believe that the ultimate resolution of our known contingencies, including the matters described in this Note, will have a material adverse effect on our consolidated financial position, liquidity or results of operations. However, there can be no assurance that the outcome of these contingencies will be favorable, and adverse results in certain of these contingencies could have a material adverse effect on our consolidated financial position, results of operations in any one reporting period, or liquidity.

See Note 1012 for the Pocatello ~~tribal~~Tribal litigation, Middleport litigation, and Portland Harbor ~~litigation~~site for legal proceedings associated with our environmental contingencies.

~~Table of Contents~~

~~FMC CORPORATION~~

~~Notes to Consolidated Financial Statements — (Continued)~~

Note ~~19:~~21: Segment Information

(in Millions) Year Ended December 31,
2017
2016
2015
Revenue⁽¹⁾

FMC Agricultural Solutions $ 2,531.2

$ 2,274.8

$ 2,252.9
FMC Lithium 347.4

264.1

238.1
Total $ 2,878.6

$ 2,538.9

$ 2,491.0
Income (loss) from continuing operations before income taxes

FMC Agricultural Solutions $ 485.6

$ 399.9

$ 363.9
FMC Lithium 126.7

70.2

23.0
Segment operating profit ⁽²⁾
$ 612.3

$ 470.1

$ 386.9
Corporate and other (102.4 )
(84.6 )
(63.0 )
Operating profit before the items listed below $ 509.9

$ 385.5

$ 323.9
Interest expense, net (79.1 )
(62.9 )
(60.9 )
Restructuring and other (charges) income ⁽³⁾
(81.4 )
(95.0 )
(150.3 )
Non-operating pension and postretirement (charges) income ⁽⁴⁾
(18.2 )
(23.4 )
(29.8 )
Acquisition related charges⁽⁵⁾
(150.4 )
(23.4 )
(290.3 )
(Provision) benefit for income taxes (264.1 )
(50.1 )
(5.2 )
Discontinued operations, net of income taxes 621.7

81.0

711.1
Net (income) loss attributable to noncontrolling interests (2.6 )
(2.6 )
(9.5 )
Net income attributable to FMC stockholders $ 535.8

$ 209.1

$ 489.0
As discussed in Note 1, we operate as a single business segment providing innovative solutions to growers around the world with a robust product portfolio fueled by a market-driven discovery and development pipeline in crop protection, plant health, and professional pest and turf management.

For revenue by major geographical region, refer to Note 3. The following table provides our long-lived assets by major geographical region:


(in Millions)	December 31,
	2020		2019
Long-lived assets (1)
North America (2)	$	1,230.2	$	1,190.7
Latin America	792.7		837.0
Europe, Middle East, and Africa (2)	1,513.9		1,448.0
Asia (2)	2,044.4		2,064.8
Total	$	5,581.2	$	5,540.5

____________________


~~(1)~~	~~Our FMC Agricultural Solutions and FMC Lithium segments each have one product line group, and therefore net sales to external customers within each of those segments are included in the table above.~~


~~(2)~~	~~Referred to as Segment Earnings.~~


~~(3)~~	~~See Note 7 for details of restructuring and other (charges) income. Below provides the detail the (charges) income by segment:~~

(1)Geographic long-lived assets exclude long-term deferred income taxes and assets of discontinued operations on the consolidated balance sheets.

(2)The countries with long-lived assets in excess of 10 percent of consolidated long-lived assets at December 31, 2020 and 2019 are Singapore, which totaled $1,582.5 million and $1,547.0 million, the U.S., which totaled $1,221.3 million and $1,177.7 million and Denmark, which totaled $1,104.6 million and $1,045.3 million, respectively.

Year Ended December 31,
(in Millions) 2017
2016
2015
FMC Agricultural Solutions $ (49.9 )
$ (62.4 )
$ (123.7 )
FMC Lithium (7.8 )
(0.6 )
(2.7 )
Corporate (23.7 )
(32.0 )
(23.9 )
Restructuring and other (charges) income $ (81.4 )
$ (95.0 )
$ (150.3 )

~~(4)~~

Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item "Selling, general and administrative expenses" on our consolidated statements of income (loss).


~~(5)~~	Charges relate to the expensing of the inventory fair value step-up resulting from the application of purchase accounting, transaction costs, costs for transitional employees, other acquired employee related costs, integration related legal and professional third-party fees and gains or losses on hedging purchase price associated with the acquisitions. Amounts represent the following:

~~Table of Contents~~

~~FMC CORPORATION~~

~~Notes to Consolidated Financial Statements — (Continued)~~

Year Ended December 31,
(in Millions) 2017
2016
2015
Acquisition-related charges - DuPont

Legal and professional fees ^{(1) (2)}
$ 130.2

$ —

$ —
Inventory fair value amortization ⁽³⁾
20.2

—

—
Acquisition-related charges - Cheminova ⁽⁴⁾

Legal and professional fees ^{(1) (2)}
$ —

$ 23.4

$ 60.4
Inventory fair value amortization ⁽³⁾
—

—

57.8
(Gain)/loss on hedging purchase price ⁽²⁾
—

—

172.1
Total acquisition-related charges $ 150.4

$ 23.4

$ 290.3

~~____________________~~


~~(1)~~	~~Represents transaction costs, costs for transitional employees, other acquired employee related costs and integration related legal and professional third-party fees.~~


~~(2)~~	~~These charges are included in “Selling, general and administrative expense" on the consolidated statements of income (loss).~~


~~(3)~~	~~These charges are included in “Costs of sales and services” on the consolidated statements of income (loss).~~


~~(4)~~	~~Acquisition-related charges and restructuring charges to integrate Cheminova with FMC Agricultural Solutions were completed at the end of 2016.~~

(in Millions) December 31,
2017 2016
Operating capital employed ⁽¹⁾

FMC Agricultural Solutions $ 6,216.3
$ 3,097.2
FMC Lithium 393.9
312.2
Total operating capital employed $ 6,610.2
$ 3,409.4
Segment liabilities included in total operating capital employed 1,957.9
1,025.0
Assets of discontinued operations held for sale 7.3
1,217.1
Corporate items 630.9
487.8
Total assets $ 9,206.3
$ 6,139.3
Segment assets ⁽²⁾

FMC Agricultural Solutions $ 8,094.0
$ 4,082.7
FMC Lithium 474.1
351.7
Total segment assets $ 8,568.1
$ 4,434.4
Assets of discontinued operations held for sale 7.3
1,217.1
Corporate items 630.9
487.8
Total assets $ 9,206.3
$ 6,139.3

~~____________________~~


~~(1)~~	We view operating capital employed, which consists of assets, net of liabilities, reported by our operations and excluding corporate items such as cash equivalents, debt, pension liabilities, income taxes and LIFO reserves, as our primary measure of segment capital.


~~(2)~~	~~Segment assets are assets recorded and reported by the segments and are equal to segment operating capital employed plus segment liabilities. See Note 1.~~

~~Table of Contents~~

~~FMC CORPORATION~~

~~Notes to Consolidated Financial Statements — (Continued)~~

Year Ended December 31,
(in Millions)
Capital Expenditures ⁽¹⁾
Depreciation and Amortization Research and Development Expense
2017 2016 2015 2017 2016 2015 2017 2016 2015
FMC Agricultural Solutions $ 26.2
$ 23.1
$ 29.2
$ 90.5
$ 80.8
$ 60.5
$ 138.4
$ 131.4
$ 132.4
FMC Lithium 47.4
24.4
17.4
15.2
14.8
12.2
3.1
3.1
3.5
Corporate 12.1
43.7
6.8
7.3
5.0
4.1
—
—
—
Total $ 85.7
$ 91.2
$ 53.4
$ 113.0
$ 100.6
$ 76.8
$ 141.5
$ 134.5
$ 135.9

~~___________________~~


~~(1)~~	Cash spending associated with contract manufacturers in our FMC Agricultural Solutions segment, which are not included in the table above was $15.9 million, $10.4 million and $14.2 million for the years ended December 31, 2017. 2016 and 2015, respectively.

~~Geographic Segment Information~~

(in Millions) Year Ended December 31,
2017 2016 2015
Revenue from continuing operations (by location of customer)
North America ⁽¹⁾
$ 708.1
$ 623.0
$ 642.7
Europe, Middle East, and Africa 583.4
558.5
372.1
Latin America ⁽¹⁾
868.6
761.2
913.8
Asia Pacific 718.5
596.2
562.4
Total $ 2,878.6
$ 2,538.9
$ 2,491.0

~~____________________~~


~~(1)~~	In 2017, countries with sales in excess of 10 percent of consolidated revenue consisted of the U.S. and Brazil. Sales for the years ended December 31, 2017, 2016 and 2015 for the U.S. totaled $655.2 million, $596.4 million and $601.2 million and for Brazil totaled $598.5 million, $490.9 million and $642.2 million, respectively.

(in Millions) December 31,
2017 2016
Long-lived assets ⁽¹⁾

North America ⁽²⁾
$ 981.1
$ 389.1
Europe, Middle East, and Africa ⁽²⁾
1,493.3
1,120.6
Latin America 925.0
375.2
Asia Pacific 1,901.5
327.5
Total $ 5,300.9
$ 2,212.4

~~____________________~~


~~(1)~~	~~Geographic segment long-lived assets exclude long-term deferred income taxes and assets of discontinued operations held for sale on the consolidated balance sheets.~~

~~(2)~~

The countries with long-lived assets in excess of 10 percent of consolidated long-lived assets at December 31, 2017 are Singapore, which totaled $1,414.9 million, the U.S., which totaled $976.9 million, and Denmark, which totaled $1,096.2 million, respectively. The long-lived assets over the threshold at December 31, 2016 are the U.S. which totaled $387.8 million and Denmark which totaled $1,030.3 million, respectively.

~~100~~

~~Table of Contents~~

~~FMC CORPORATION~~

~~Notes to Consolidated Financial Statements — (Continued)~~

Note ~~20:~~22: Supplemental Information

103

Table of Contents

FMC CORPORATION

Notes to Consolidated Financial Statements — (Continued)

The following tables present details of prepaid and other current assets, other assets including long-term receivables, net, accrued and other liabilities and other long-term liabilities as presented on the consolidated balance sheets:


(in Millions)	December 31,
	2020		2019
Prepaid and other current assets
Prepaid insurance	$	11.1	$	8.2


Tax related items including value added tax receivables	197.7		229.2
Refund asset (1)	28.4		37.7
Environmental obligation recoveries (Note 12)	0.8		12.3
Derivative assets (Note 19)	0.3		0.2

Acquisition related items	3.0		3.0

Other prepaid and current assets	139.5		196.9
Total	$	380.8	$	487.5

(in Millions) December 31,
2017 2016
Prepaid and other current assets
Prepaid insurance $ 8.2
$ 7.7
Tax related items including value added tax receivables 127.3
115.4
Environmental obligation recoveries (Note 10) 7.0
8.4
Derivative assets (Note 17) 6.7
6.4
Argentina government receivable ⁽¹⁾
3.2
5.1
Acquisition related items ⁽²⁾
54.7
—
Other prepaid and current assets 119.3
89.1
Total $ 326.4
$ 232.1


(in Millions)	December 31,				(in Millions)	December 31,
	2017		2016			2020		2019
Other assets including long-term receivables, net					Other assets including long-term receivables, net
Non-current receivables (Note 8)	$	106.7	$	123.5
Non-current receivables (Note 10)					Non-current receivables (Note 10)	$	103.5	$	123.1
Advance to contract manufacturers	79.1		75.1		Advance to contract manufacturers	122.2		116.3
Capitalized software, net	26.6		31.7		Capitalized software, net	158.0		117.0
Environmental obligation recoveries (Note 10)	25.3		18.8
Argentina government receivable ⁽¹⁾	44.5		41.7
Income taxes deferred charges	67.2		80.6
Deferred compensation arrangements	30.1		25.3
Environmental obligation recoveries (Note 12)					Environmental obligation recoveries (Note 12)	3.6		15.0

Income taxes indirect benefits					Income taxes indirect benefits	37.9		32.7
Operating lease ROU asset (Note 4)					Operating lease ROU asset (Note 4)	147.3		164.7
Deferred compensation arrangements (Note 19)					Deferred compensation arrangements (Note 19)	24.1		20.2
Pension and other postretirement benefits (Note 15)					Pension and other postretirement benefits (Note 15)	69.5		44.2
Other long-term assets	64.1		58.0		Other long-term assets	46.2		52.1
Total	$	443.6	$	454.7	Total	$	712.3	$	685.3

____________________

~~(1)~~

We have various subsidiaries that conduct business within Argentina, primarily in our FMC Agricultural Solutions and FMC Lithium segments. At December 31, 2017 and 2016, $37.9 million and $39.1 million of outstanding receivables due from the Argentina government, which primarily represent export tax and export rebate receivables, were denominated in U.S. dollars. As with all outstanding receivable balances we continually review recoverability by analyzing historical experience, current collection trends and regional business and political factors among other factors.

~~(2)~~

Represents $32.9 million of accounts payable of the legal entity stock sales as part of the DuPont Crop Protection Acquisition as well as $21.8 million of deferred goodwill as a result of the delayed sites. As part of the Transaction Agreement, the accounts payable will be settled subsequent to the closing date through reimbursement between FMC and DuPont. This amount represents the offsetting asset recorded for amounts due back from DuPont. The deferred goodwill will be recognized as the sites are transferred to FMC. See Note 3 for more details.

(1) In accordance with revenue standard requirements, a sales return liability is recognized for the consideration paid by a customer to which FMC does not expect to be entitled, together with a corresponding refund asset to recover the product from the customer.


(in Millions)	December 31,
	2020		2019
Accrued and other liabilities
Restructuring reserves (Note 9)	$	11.9	$	8.1
Dividend payable (Note 17)	62.3		57.0
Accrued payroll	87.0		101.2

Environmental reserves, current, net of recoveries (Note 12)	120.9		115.3
Derivative liabilities (Note 19)	24.8		8.9
Furadan® product exit asset retirement obligations	10.0		33.0
Unfavorable contracts (1)	105.8		109.2
Operating lease current liabilities (Note 4)	25.6		31.5
Other accrued and other liabilities (2)	226.4		216.4
Total	$	674.7	$	680.6

~~101~~

104

Table of Contents

FMC CORPORATION

Notes to Consolidated Financial Statements — (Continued)

(in Millions) December 31,
2017 2016
Accrued and other liabilities
Restructuring reserves (Note 7) $ 6.5
$ 15.9
Dividend payable (Note 15) 22.3
22.1
Accrued payroll 92.4
55.2
Environmental reserves, current, net of recoveries (Note 10) 72.0
60.3
Derivative liabilities (Note 17) 2.3
8.9
Acquisition related items ⁽¹⁾
45.8
—
Unfavorable contracts ⁽²⁾
65.7
—
Other accrued and other liabilities 190.7
196.1
Total $ 497.7
$ 358.5

(in Millions) December 31,
2017 2016
Other long-term liabilities
Asset retirement obligations, long-term (Note 1) $ 1.9
$ 1.8
Transition tax related to Tax Cuts and Jobs Act ⁽³⁾
186.5
—
Contingencies related to uncertain tax positions (Note 11) 93.9
101.6
Deferred compensation arrangements (Note 17) 38.8
30.5
Self insurance reserves (primarily workers' compensation) 6.1
9.9
Lease obligations 22.5
28.0
Reserve for discontinued operations (Note 9) 63.2
48.6
Guarantees of vendor financing (Note 18) 0.2
1.9
Unfavorable contracts ⁽²⁾
243.9
—
Other long-term liabilities 61.1
45.2
Total $ 718.1
$ 267.5


(in Millions)	December 31,
	2020		2019
Other long-term liabilities
Restructuring reserves (Note 9)	$	4.5	$	6.5
Asset retirement obligations, long-term (Note 1)	20.7		2.7
Transition tax related to Tax Cuts and Jobs Act (3)	107.8		123.6
Contingencies related to uncertain tax positions (Note 13)	83.1		71.4
Deferred compensation arrangements (Note 19)	35.2		29.7
Derivative liabilities (Note 19)	0.8		0.2
Self-insurance reserves (primarily workers' compensation)	1.9		1.8
Lease obligations (Note 4)	151.1		163.2
Reserve for discontinued operations (Note 11)	76.6		71.9

Unfavorable contracts (1)	89.4		206.0
Other long-term liabilities	32.7		31.4
Total	$	603.8	$	708.4

____________________


~~(1)~~	Represents the accounts receivable of the legal entity stock sales as part of the DuPont Crop Protection Acquisition. As part of the Transaction Agreement, this balance will be settled subsequent to the closing date through reimbursement between FMC and DuPont. Amount represents the offsetting liability recorded for amounts due back to DuPont.


~~(2)~~	~~Represents the technical insecticide product supply agreements with DuPont for use in their retained seed treatment business. Refer to Note 3~~ (1) Primarily represents the technical insecticide product supply agreements with DuPont for use in their retained seed treatment business. Refer to Note 5 for more details.


~~(3)~~	~~Represents noncurrent portion of overall transition tax to be paid over eight years.~~

(2) Other accrued and other liabilities includes the gross up of the estimated sales returns as part of our adoption of ASC 606. The impact of the adoption impacted accrued and other liabilities by $28.4 million and $37.7 million, respectively.

(3) Represents noncurrent portion of overall transition tax to be paid over the next five years.

~~102~~

105

Table of Contents

FMC CORPORATION

Notes to Consolidated Financial Statements — (Continued)

Note ~~21:~~23: Quarterly Financial Information (Unaudited)


(in Millions, Except Share and Per Share Data)	2020								2019
	1Q		2Q		3Q		4Q		1Q		2Q		3Q		4Q
Revenue	$	1,250.0	$	1,155.3	$	1,084.6	$	1,152.2	$	1,192.1	$	1,206.1	$	1,014.3	$	1,197.3
Gross margin	561.5		522.7		466.4		501.4		544.7		550.5		432.4		556.0
Income (loss) from continuing operations before equity in (earnings) loss of affiliates, non-operating pension and postretirement charges (income), interest expense, net and income taxes	291.4		267.9		196.0		146.9		281.8		267.8		159.9		112.1
Income (loss) from continuing operations	213.7		195.8		130.5		38.9		207.6		194.4		110.8		30.7
Discontinued operations, net of income taxes	(7.5)		(10.8)		(18.4)		8.4		9.6		(18.1)		(21.3)		(33.5)
Net income (loss)	$	206.2	$	185.0	$	112.1	$	47.3	$	217.2	$	176.3	$	89.5	$	(2.8)
Less: Net income (loss) attributable to noncontrolling interests	0		0.6		0.7		(2.2)		1.5		1.8		(0.9)		0.4
Net income (loss) attributable to FMC stockholders	$	206.2	$	184.4	$	111.4	$	49.5	$	215.7	$	174.5	$	90.4	$	(3.2)
Amounts attributable to FMC stockholders:
Continuing operations, net of income taxes	$	213.7	$	195.2	$	129.8	$	41.1	$	206.1	$	192.6	$	111.7	$	30.3
Discontinued operations, net of income taxes	(7.5)		(10.8)		(18.4)		8.4		9.6		(18.1)		(21.3)		(33.5)
Net income (loss)	$	206.2	$	184.4	$	111.4	$	49.5	$	215.7	$	174.5	$	90.4	$	(3.2)
Basic earnings (loss) per common share attributable to FMC stockholders (1):
Continuing operations	$	1.65	$	1.50	$	1.00	$	0.32	$	1.56	$	1.46	$	0.85	$	0.23
Discontinued operations	(0.06)		(0.08)		(0.14)		0.06		0.07		(0.14)		(0.16)		(0.25)
Basic net income (loss) per common share	$	1.59	$	1.42	$	0.86	$	0.38	$	1.63	$	1.32	$	0.69	$	(0.02)
Diluted earnings (loss) per common share attributable to FMC stockholders (1):
Continuing operations	$	1.64	$	1.49	$	0.99	$	0.32	$	1.55	$	1.46	$	0.85	$	0.23
Discontinued operations	(0.06)		(0.08)		(0.14)		0.06		0.07		(0.14)		(0.16)		(0.25)
Diluted net income (loss) per common share	$	1.58	$	1.41	$	0.85	$	0.38	$	1.62	$	1.32	$	0.69	$	(0.02)
Weighted average shares outstanding:
Basic	129.5		129.7		129.9		129.8		131.9		131.1		130.4		129.7
Diluted	130.5		130.6		130.8		130.7		133.2		132.3		131.6		130.9

____________________

(1)The sum of quarterly earnings per common share may differ from the full-year amount.

106

(in Millions, Except Share and Per Share Data) 2017 2016
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q
Revenue $ 596.0
$ 656.8
$ 646.2
$ 979.6
$ 606.4
$ 615.3
$ 628.8
$ 688.4
Gross margin 216.2
234.4
265.9
384.8
216.0
235.4
214.6
265.2
Income (loss) from continuing operations before equity in (earnings) loss of affiliates, net interest income and expense and income taxes 54.4
52.0
59.3
43.0
62.2
82.5
70.0
28.5
Income (loss) from continuing operations ⁽¹⁾
45.0
48.7
70.9
(247.9 ) 26.0
46.8
48.5
9.4
Discontinued operations, net of income taxes ⁽²⁾
(168.8 ) 26.6
(15.1 ) 779.0
22.7
20.2
31.1
7.0
Net income (loss) $ (123.8 ) $ 75.3
$ 55.8
$ 531.1
$ 48.7
$ 67.0
$ 79.6
$ 16.4
Less: Net income (loss) attributable to noncontrolling interests 0.4
0.6
0.6
1.0
0.4
1.8
(0.1 ) 0.5
Net income (loss) attributable to FMC stockholders $ (124.2 ) $ 74.7
$ 55.2
$ 530.1
$ 48.3
$ 65.2
$ 79.7
$ 15.9
Amounts attributable to FMC stockholders:
Continuing operations, net of income taxes $ 44.5
$ 48.2
$ 70.4
$ (249.0 ) $ 25.6
$ 45.0
$ 48.9
$ 8.9
Discontinued operations, net of income taxes (168.7 ) 26.5
(15.2 ) 779.1
22.7
20.2
30.8
7.0
Net income (loss) $ (124.2 ) $ 74.7
$ 55.2
$ 530.1
$ 48.3
$ 65.2
$ 79.7
$ 15.9
Basic earnings (loss) per common share attributable to FMC stockholders ⁽³⁾:

Continuing operations $ 0.33
$ 0.36
$ 0.52
$ (1.85 ) $ 0.19
$ 0.34
$ 0.36
$ 0.07
Discontinued operations (1.26 ) 0.20
(0.11 ) 5.79
0.17
0.15
0.23
0.05
Basic net income (loss) per common share $ (0.93 ) $ 0.56
$ 0.41
$ 3.94
$ 0.36
$ 0.49
$ 0.59
$ 0.12
Diluted earnings (loss) per common share attributable to FMC stockholders ⁽³⁾:

Continuing operations $ 0.33
$ 0.36
$ 0.52
$ (1.85 ) $ 0.19
$ 0.34
$ 0.36
$ 0.07
Discontinued operations (1.25 ) 0.20
(0.11 ) 5.79
0.17
0.15
0.23
0.05
Diluted net income (loss) per common share $ (0.92 ) $ 0.56
$ 0.41
$ 3.94
$ 0.36
$ 0.49
$ 0.59
$ 0.12
Weighted average shares outstanding:
Basic 134.0
134.2
134.4
134.5
133.8
133.9
134.0
133.9
Diluted 135.1
135.6
135.9
134.5
134.3
134.6
134.7
134.8

~~____________________~~


~~(1)~~	~~The Company recorded a provisional income tax expense of $315.9 million as a result of the enactment of the Act during the fourth quarter of 2017. See Note 11 for more details.~~


~~(2)~~	In the first quarter of 2017, we recorded an impairment charge associated with our discontinued Omega-3 business. In the fourth quarter of 2017, we recorded a gain on sale of the FMC Health and Nutrition business. See Note 9 for more details.


~~(3)~~	~~The sum of quarterly earnings per common share may differ from the full-year amount.~~

~~103~~

Table of Contents

Report of Independent Registered Public Accounting Firm

~~The~~To the Stockholders and Board of Directors ~~and Stockholders~~

FMC Corporation:

Opinion on the ConsolidatedFinancial Statements

We have audited the accompanying consolidated balance sheets of FMC Corporation and subsidiaries (the ~~“Company”)~~Company) as of December 31, ~~2017~~2020 and ~~2016,~~2019, the related consolidated statements of income (loss), comprehensive income (loss), changes in equity, and cash flows for each of the years in the three‑year period ended December 31, ~~2017,~~2020, and the related notes and ~~financial statement~~ schedule II -– valuation and qualifying accounts and reserves (collectively, the ~~“consolidated~~consolidated financial ~~statements”)~~statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, ~~2017~~2020 and ~~2016,~~2019, and the results of its operations and its cash flows for each of the years in the three‑year period ended December 31, ~~2017,~~2020, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) ~~(“PCAOB”)~~(PCAOB), the Company’s internal control over financial reporting as of December 31, ~~2017,~~2020, based on criteria established in Internal Control -– Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February ~~28, 2018~~25, 2021 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

Change in Accounting Principle

As discussed in Note 2 to the consolidated financial statements, the Company has changed its method of accounting for leases as of January 1, 2019 due to the adoption of Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842) and the related amendments.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Evaluation of the allowance for trade receivables and long-term receivables associated with customers located in Brazil

As discussed in Notes 1 and 10 to the consolidated financial statements, the Company develops an analysis of trade receivables and long-term receivables to determine its best estimate of the probable losses associated with potential customer defaults. The most significant portion of the allowance for trade receivables and long-term receivables is related to customers located in Brazil.

We identified the evaluation of the allowance for trade receivables and long-term receivables associated with customers located in Brazil as a critical auditing matter. Specifically, the length of standard credit terms offered and customer liquidity may be significantly influenced by economic conditions and unfavorable weather conditions impacting crop quality. This increased the need for subjective judgment and knowledge in assessing customer liquidity constraints to estimate probable losses.

107

Table of Contents

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s collectability determination process, including controls over the identification of at-risk trade receivables and long-term receivables balances and related estimate of probable losses associated with such balances. We inspected underlying documentation for collateral arrangements, legal disputes, and historical trends and analysis performed by the Company for historical collection results. The Company’s assumptions underlying the collectability of trade receivables and long-term receivables were tested by evaluating:

•The Company’s rationale for and appropriateness of changes in assumptions from those used in the prior year related to its expected collection period for specific customers;

•Local Brazil economic and weather conditions that might impact the assumptions;

•Adjustments to the prior period reserve and assessing if those adjustments provided information that was contradictory to the current year’s assumptions; and

•Deterioration of trade receivables and long-term receivables balances subsequent to year-end, to identify the presence of trends not considered by the Company when it developed its assumptions.

Evaluation of unrecognized tax benefits

As discussed in Note 13, the Company has $76.2 million of unrecognized tax benefits as of December 31, 2020. The Company recognizes the largest amount of tax benefit that it believes is more than 50 percent likely to be sustained. A significant amount of the Company’s earnings are generated by certain foreign subsidiaries whose earnings are taxed at lower rates than the United States federal statutory rate.

We identified the evaluation of the Company’s unrecognized tax benefits related to the earnings of certain foreign subsidiaries as a critical audit matter. Complex auditor judgment was required in evaluating the Company’s interpretation of tax law, the transfer pricing structure, and its analysis of the recognition of its tax benefits.

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the unrecognized tax benefits process, including controls related to the transfer pricing structure which affects the determination of earnings of certain foreign subsidiaries. We also involved tax and transfer pricing professionals with specialized skills and knowledge, who assisted in:

•Examining the Company’s tax positions, including the methodology for evaluating unrecognized tax benefits;

•Assessing transfer pricing studies with applicable laws and regulations;

•Evaluating the Company’s interpretation of tax laws and income tax consequences of intercompany transactions;

•Considering applicable settlements with taxing authorities; and

•Evaluating the Company’s determination of unrecognized tax benefits.

/s/ KPMG LLP

We have served as the Company's auditor since 1928.

Philadelphia, Pennsylvania

February ~~28, 2018~~

25, 2021

~~104~~

108

Table of Contents

MANAGEMENT’S ANNUAL REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Exchange Act Rule 13a-15(f). FMC’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Internal control over financial reporting includes those written policies and procedures that:

•pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of FMC;

•provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles;

•provide reasonable assurance that receipts and expenditures of FMC are being made only in accordance with authorization of management and directors of FMC; and

•provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the consolidated financial statements.

Internal control over financial reporting includes the controls themselves, monitoring and internal auditing practices and actions taken to correct deficiencies as identified.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

We assessed the effectiveness of our internal control over financial reporting as of December 31, ~~2017.~~2020. We based this assessment on criteria for effective internal control over financial reporting described in ~~“Internal~~"Internal Control—Integrated Framework (COSO 2013)”" issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management’s assessment included an evaluation of the design of our internal control over financial reporting and testing of the operational effectiveness of our internal control over financial reporting. We reviewed the results of our assessment with the Audit Committee of our Board of Directors.

FMC acquired DuPont’s Crop Protection Business during 2017, and we excluded from our assessment of the effectiveness of FMC’s internal control over financial reporting as of December 31, 2017, the Crop Protection Business’s internal control over financial reporting which represented 42% of FMC’s consolidated total assets (including amounts resulting from the purchase price allocation) and 7% of consolidated revenues as of and for the year ended December 31, 2017.

Based on this assessment, we determined that, as of December 31, ~~2017,~~2020, FMC has effective internal control over financial reporting.

KPMG LLP, our independent registered public accounting firm, has issued an attestation report on the effectiveness of internal control over financial reporting as of December 31, ~~2017,~~2020, which appears on the following page.

~~105~~

109

Table of Contents

Report of Independent Registered Public Accounting Firm

~~The~~To the Stockholders and Board of Directors ~~and Stockholders~~

FMC Corporation:

Opinion on Internal Control Over Financial Reporting

We have audited FMC Corporation and subsidiaries’ (the ~~“Company”)~~Company) internal control over financial reporting as of December 31, ~~2017,~~2020, based on criteria established inInternal Control -– Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, ~~2017,~~2020, based on criteria established in Internal Control -– Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) ~~(“PCAOB”)~~(PCAOB), the consolidated balance sheets of the Company as of December 31, ~~2017~~2020 and ~~2016, and~~2019, the related consolidated statements of income (loss), comprehensive income (loss), changes in equity, and cash flows for each of the years in the three-year period ended December 31, ~~2017,~~2020, and the related notes and ~~financial statement~~ schedule II -– valuation and qualifying accounts and reserves (collectively, the consolidated financial statements), and our report dated February ~~28, 2018~~25, 2021 expressed an unqualified opinion on those consolidated financial statements.

The Company acquired DuPont’s Crop Protection Business during 2017, and management excluded from its assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2017, the Crop Protection Business’ internal control over financial reporting which represented 42% of the Company’s total assets (including amounts resulting from the purchase price allocation) and 7% of consolidated revenue as of and for the year ended December 31, 2017. Our audit of internal control over financial reporting of the Company also excluded an evaluation of the internal control over financial reporting of the Crop Protection Business.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

~~106~~

~~Table of Contents~~

/s/ KPMG LLP

Philadelphia, Pennsylvania

February ~~28, 2018~~25, 2021

~~107~~

110

Table of Contents

FMC CORPORATION

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES

~~FOR YEARS ENDED DECEMBER 31, 2017, 2016 and 2015~~


			Provision /(Benefit)											Provision (Benefit)
(in Millions)	Balance, Beginning of Year		Charged to Costs and Expenses		Charged to Other Comprehensive Income		Net recoveries and write-offs ⁽¹⁾		Balance, End of Year		(in Millions)	Balance, Beginning of Year		Charged to Costs and Expenses	Charged to Other Comprehensive Income	Net recoveries, write-offs and other (1)	Balance, End of Year
December 31, 2017
December 31, 2020											December 31, 2020
Reserve for doubtful accounts ⁽²⁾	$	66.7	22.1		—		(3.0	)	$	85.8	Reserve for doubtful accounts (2)	$	87.4	4.7	0	(39.5)	$	52.6
Deferred tax valuation allowance	289.6		(20.2	)	2.6		—		272.0		Deferred tax valuation allowance	303.3		34.0	(1.7)	0	335.6
December 31, 2016
December 31, 2019											December 31, 2019
Reserve for doubtful accounts ⁽²⁾	$	43.1	21.9		—		1.7		$	66.7	Reserve for doubtful accounts (2)	$	82.9	21.2	0	(16.7)	$	87.4
Deferred tax valuation allowance	273.2		19.8		(3.4	)	—		289.6		Deferred tax valuation allowance	261.4		42.2	(0.3)	0	303.3
December 31, 2015
Reserve for doubtful accounts	$	37.1	5.9		—		0.1		$	43.1
December 31, 2018											December 31, 2018
Reserve for doubtful accounts (2)(3)											Reserve for doubtful accounts (2)(3)	$	85.7	71.4	0	(74.2)	$	82.9
Deferred tax valuation allowance	118.9		153.9		0.4		—		273.2		Deferred tax valuation allowance	272.0		(8.8)	(1.8)	0	261.4

____________________


~~(1)~~	~~Write-offs are net of recoveries.~~


~~(2)~~	~~Includes short-term and long-term portion.~~

(1)Write-offs are net of recoveries.

(2)Includes short-term and long-term portion.

(3)Includes the charge and write-off of approximately $42 million associated with the stranded accounts receivables written off as part of the restructuring in India. The charge was recorded as a component of "Restructuring and other charges (income)" on the consolidated statements of income (loss).


~~ITEM 9.~~	~~CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE~~

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Management’s annual report on internal control over financial reporting. Refer to Management’s Annual Report on Internal Control Over Financial Reporting which is included in Item 8 of Part II of this Annual Report on Form 10-K and is incorporated by reference to this Item 9A.

Audit report of the independent registered public accounting firm. Refer to Report of Independent Registered Public Accounting Firm which is included in Item 8 of Part II of this Annual Report on Form 10-K and is incorporated by reference to this Item 9A.

(b) Change in Internal Controls. ~~In connection with~~During the ~~acquisition~~fourth quarter of 2020, we completed the final phase of our ERP implementation by migrating the remaining legacy entities to the new system. As a ~~significant portion of the DuPont Crop Protection Business, the Company entered into a transitional services agreement with DuPont for DuPont~~result, we have implemented updates and changes to ~~provide information technology services, accounting, human resource and facility services, business~~our current processes and ~~associated internal controls for a period of up to 24 months with an optional six month extension in order to allow for an orderly separation~~related control activities and ~~transition of various functions and processes. Management has established controls to mitigate~~have evaluated the risk over financial reporting and will continue to monitor and evaluate the sufficiency of the controls. The Company is currently evaluating the acquired DuPont Crop Protection Business processes, information technology systems, and other components of internal controls over financial reporting as a part of the Company's integration activities which may result in periodic control changes. Such changes will be disclosed as required by applicable SEC guidance.

~~108~~

~~Table of Contents~~

~~(c) The scope of management’s assessment of the~~operating effectiveness of its internal control over financial reporting included the Company’s consolidated operations except for the operations of the DuPont Crop Protection Business, which FMC acquired on November 1, 2017. The DuPont Crop Protection Business represented 42% of the Company’s total assets (including amounts resulting from the purchase price allocation) and 7% of the consolidated revenue as of and for the year ended December 31, 2017. The DuPont Crop Protection Business will be included within scope of management's assessment of its internal control over financial reporting in the Company's Annual Report on Form 10-K for the year ending December 31, 2018.related key controls.

ITEM 9B. OTHER INFORMATION

None.

111

~~109~~

Table of Contents

PART III

~~Item~~ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Information concerning directors, appearing under the caption ~~“III.~~"III. Board of ~~Directors”~~Directors" in our Proxy Statement to be filed with the SEC in connection with the Annual Meeting of Stockholders scheduled to be held on April ~~24, 2018~~27, 2021 (the ~~“Proxy Statement”~~"Proxy Statement"), information concerning executive officers, appearing under the caption ~~“Item~~"Item 4A. Information about our Executive ~~Officers of the Registrant”~~Officers" in Part I of this Annual Report on Form 10-K, information concerning the Audit Committee, appearing under the caption ~~“IV.~~"IV. Information About the Board of Directors and Corporate Governance - Committees and Independence of Directors - Audit ~~Committee”~~Committee" in the Proxy Statement, and information concerning the Code of Ethics, appearing under the caption ~~“IV.~~"IV. Information About the Board of Directors and Corporate Governance - Corporate Governance - Code of Ethics and Business Conduct Policy” in the Proxy Statement, and information about compliance with Section 16(a) of the Securities Exchange Act of 1934 appearing under the caption “VII. Other Matters - Section 16(a) Beneficial Ownership Reporting Compliance”Policy" in the Proxy Statement, is incorporated herein by reference in response to this Item 10.

ITEM 11. EXECUTIVE COMPENSATION

The information contained in the Proxy Statement in the section titled ~~“VI.~~"VI. Executive ~~Compensation”~~Compensation" with respect to executive compensation, in the section titled ~~“IV.~~"IV. Information About the Board of Directors and Corporate Governance—Director ~~Compensation”~~Compensation" and “—"—Corporate Governance—Compensation and Organization Committee Interlocks and Insider ~~Participation”~~Participation" is incorporated herein by reference in response to this Item 11.


~~ITEM 12.~~	~~SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS~~

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information contained in the section titled ~~“V.~~"V. Security Ownership of FMC ~~Corporation”~~Corporation" in the Proxy Statement, with respect to security ownership of certain beneficial owners and management, is incorporated herein by reference in response to this Item 12.

Equity Compensation Plan Information

The table below sets forth information with respect to compensation plans under which equity securities of FMC are authorized for issuance as of December 31, ~~2017.~~2020. All of the equity compensation plans pursuant to which we are currently granting equity awards have been approved by stockholders.

~~(Shares~~


(Shares in thousands)	Number of Securities to be issued upon exercise of outstanding options and restricted stock awards (A) (2)	Weighted-average exercise price of outstanding options awards (B) (1)		Number of Securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (A)) (C)
Equity Compensation Plans approved by stockholders	2,003	$	70.44	3,200

____________________

(1)Taking into account all outstanding awards included in ~~thousands, except per share data)~~this table, the weighted-average exercise price of such stock options is $70.44 and the weighted-average term-to-expiration is 7.0 years.

(2)Includes 1,235 thousand stock options and 500 thousand restricted stock awards granted to employees and 268 thousand restricted stock units held by directors.

Plan Category
Number of Securities to be issued upon exercise of outstanding options and restricted stock awards (A) ⁽²⁾

Weighted-average exercise price of outstanding options awards (B) ⁽¹⁾
Number of Securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (A)) (C)
Equity Compensation Plans approved by stockholders 3,412
$ 48.37
5,123


~~(1)~~	~~Taking into account all outstanding awards included in this table, the weighted-average exercise price of such stock options is $48.37 and the weighted-average term-to-expiration is 6.3 years.~~


~~(2)~~	~~Includes 2,435 thousand stock options and 749 thousand restricted stock awards granted to employees and 228 thousand Restricted Stock Units held by directors.~~


~~ITEM 13.~~	~~CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE~~

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information contained in the Proxy Statement concerning our independent directors and related party transactions under the caption ~~“IV.~~"IV. Information About the Board of Directors and Corporate ~~Governance-~~ Governance—Committees and Independence of Directors,”" and the information contained in the Proxy Statement concerning our related party transactions policy, appearing under the caption ~~“IV.~~"IV. Information About the Board of Directors and Corporate Governance—Corporate Governance—Related Party Transactions Policy,”" is incorporated herein by reference in response to this Item 13.

~~110~~

~~Table of Contents~~


~~ITEM 14.~~	~~PRINCIPAL ACCOUNTANT FEES AND SERVICES~~

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information contained in the Proxy Statement in the section titled ~~“II.~~"II. The Proposals to be Voted On—Ratification of Appointment of Independent Registered Public Accounting ~~Firm”~~Firm" is incorporated herein by reference in response to this Item 14.

112

Table of Contents

PART IV


~~ITEM 15.~~	~~EXHIBITS AND FINANCIAL STATEMENT SCHEDULES~~


~~(a)~~	~~Documents filed with this Report~~

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)Documents filed with this Report

1. Consolidated financial statements of FMC Corporation and its subsidiaries are incorporated under Item 8 of this Form 10-K.

2. The following supplementary financial information is filed in this Form 10-K:



			Page
Financial Statements Schedule II – Valuation and qualifying accounts and reserves for the years ended December 31, ~~2017, 2016~~2020, 2019, and ~~2015~~2018			~~108~~111

The schedules not included herein are omitted because they are not applicable or the required information is presented in the financial statements or related notes.

3. ~~Exhibits: See attached Index~~Exhibits – The following exhibits are filed as a part of, or incorporated by reference into, this Form 10-K:

(a)Exhibits


~~(b)~~	~~Exhibits~~



Exhibit No.			Exhibit Description
(2(2)		)	Plan of acquisition, reorganization, arrangement, liquidation or succession

*2.1a				Stock and Asset Purchase Agreement, dated as of February 3, 2015, by and among FMC Corporation, Tronox US Holdings Inc. and Tronox Limited (Exhibit 2.1 to the Current Report on Form 8-K/A filed on February 4, 2015)

*2.1b		Transaction Agreement, dated March 31, 2017, by and between E.I. du Pont de Nemours and Company and FMC Corporation (Exhibit 2.1 to the Current Report on Form 8-K filed on April 4, 2017)

*~~2.1c~~			2.1b	Purchase Price Allocation Side Letter Agreement, dated as of May 12, 2017, by and between ~~the~~E. I. du Pont de Nemours and Company and FMC Corporation (Exhibit 10.26 to the Quarterly Report on Form 10-Q filed on November 7, 2017)

(3(3)		)	Articles of Incorporation and By-Laws

*3.1				Restated Certificate of Incorporation, as amended through ~~May 23, 2013~~April 30, 2019 (Exhibit 3.1 to the Quarterly Report on Form 10-Q filed on ~~July 30, 2013)~~May 8, 2019)

*3.2				Restated By-Laws of FMC Corporation as of ~~December 22, 2016~~April 30, 2019 (Exhibit 3.2 to the ~~Annual~~Quarterly Report on Form ~~10-K~~10-Q filed on ~~February 28, 2017)~~May 8, 2019)

(4(4)		)	Instruments defining the rights of security holders, including indentures. FMC Corporation undertakes to furnish to the SEC upon request, a copy of any instrument defining the rights of holders of long-term debt of FMC Corporation and its consolidated subsidiaries and for any of its unconsolidated subsidiaries for which financial statements are required to be filed.

*4.1				Indenture, dated as of November 15, 2009, by and between FMC Corporation and U.S. Bank National Association, as trustee (Exhibit 4.1 to the Current Report on Form 8-K filed on November 30, 2009)

*4.2				First Supplemental Indenture, dated as of November 30, 2009, by and between FMC Corporation and U.S. Bank National Association, as trustee (including the form of the Note) (Exhibit 4.2 to the Current Report on Form 8-K filed on November 30, 2009)

*4.3				Second Supplemental Indenture, dated as of November 22, 2011, by and between the Company and U.S. Bank National Association, as trustee (including the form of the Note) (Exhibit 4.2 to the Current Report on Form 8-K filed on November 22, 2011)

*4.4				Third Supplemental Indenture, dated as of November 15, 2013, by and between the Company and U.S. Bank National Association, as trustee (including the form of the Note) (Exhibit 4.1 to the Current Report on Form 8-K filed on November 15, 2013)

~~(10~~	)	~~Material contracts~~

~~111~~

~~Table of Contents~~




*~~10.1~~	4.5	~~Credit Agreement,~~Fourth Supplemental Indenture, dated as of ~~August 5, 2011, among FMC Corporation~~September 20, 2019, by and ~~certain Foreign Subsidiaries,~~between the Lenders and Issuing Banks Parties Thereto, Citibank, N.A., as Administrative Agent, Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as Joint Lead Arrangers, Bank of America, N.A., as Syndication Agent, DNB NOR Bank ASA, The Bank of Tokyo-Mitsubishi UFJ, Ltd., and Sumitomo Mitsui Banking Corp., as Co-Documentation Agents, and DNB NOR Bank ASA, The Bank of Tokyo-Mitsubishi UFJ, Ltd., Sumitomo Mitsui Banking Corp., BNP Paribas, HSBC Bank USA, National Association,Company and U.S. Bank National Association, as ~~Co-Senior Managing Agents~~trustee (including the forms of the Notes attached as Exhibit A, Exhibit B and Exhibit C thereto) (Exhibit ~~10.1~~4.2 to the Current Report on Form 8-K filed on ~~August 8, 2011)~~September 23, 2019)

*~~10.1a~~			4.6	~~Amendment and Consent No. 1, dated as~~Description of ~~August 5, 2013,~~Capital Stock (Exhibit 4.6 to the Credit Agreement, dated as of August 5, 2011, among FMC Corporation, certain subsidiaries of FMC Corporation party thereto, the lenders and issuing banks party thereto, and Citibank, N.A., as Administrative Agent for such lenders (Exhibit 10.1 to the QuarterlyAnnual Report on Form ~~10-Q~~10-K filed on ~~October 29, 2013)~~February 28, 2020)

*10.1b(10)			Amended and Restated Credit Agreement, dated as of October 10, 2014, among FMC Corporation, certain subsidiaries of FMC Corporation party thereto, the lenders and issuing banks party thereto, and Citibank, N.A., as Administrative Agent for such lenders (Exhibit 10.1 to the Current Report on Form 8-K filed on October 14, 2014) Material contracts

*~~10.1c~~			10.1a	Term Loan Agreement, dated as of October 10, 2014, among FMC Corporation, certain subsidiaries of FMC Corporation party thereto, the lenders party thereto, and Citibank, N.A., as Administrative Agent for such lenders (Exhibit 10.2 to the Current Report on Form 8-K filed on October 14, 2014)

*10.1d		Amendment No. 2, dated as of March 24, 2016, to the Amended and Restated Credit Agreement, dated as of October 10, 2014, among FMC Corporation, certain subsidiaries of FMC Corporation party thereto, the lenders and issuing party thereto, and Citibank, N.A., as Administrative Agent for such lenders (Exhibit 10.1 to the Current Report on Form 8-K filed on March 28, 2016)

*10.1e		Amendment No. 2, dated as of March 24, 2016, to the Term Loan Agreement, dated as of October 10, 2014, among FMC Corporation, certain subsidiaries of FMC Corporation party thereto, the lenders and issuing party thereto, and Citibank, N.A., as Administrative Agent for such lenders (Exhibit 10.2 to the Current Report on Form 8-K filed on March 28, 2016)

*10.1f		Amendment No. 3, dated as of May 2, 2017, to the Term Loan Agreement, dated as of October 10, 2014, among FMC Corporation, certain subsidiaries of FMC Corporation party thereto, the lenders and issuing party thereto, and Citibank, N.A., as Administrative Agent for such lenders (Exhibit 10.3 to the Current Report on Form 8-K filed on May 2, 2017)

*10.1g		Term Loan Agreement, dated as of May 2, 2017, among FMC Corporation, certain subsidiaries of FMC Corporation party thereto, the lenders party thereto, and Citibank, N.A., as Administrative Agent for such lenders. (Exhibit 10.2 to the Current Report on Form 8-K filed on May 2, 2017)

113

Table of Contents



*10.1b	Amendment No. 1, dated September 28, 2018, to the Term Loan Agreement, dated as of May 2, 2017, among FMC Corporation, certain subsidiaries of FMC Corporation from time to time party thereto as borrowers, Citibank, N.A., as Administrative Agent, each lender from time to time party thereto and the other parties thereto. (Exhibit 10.2 to the Current Report on Form 8-K filed on October 3, 2018)

*~~10.1h~~	10.1c	~~Second~~Third Amended and Restated Credit Agreement, dated as of May ~~2, 2017,~~17, 2019, among FMC Corporation, certain subsidiaries of FMC Corporation party thereto, the lenders and issuing banks party thereto, and Citibank, N.A., as Administrative Agent for such lenders. (Exhibit 10.1 to the Current Report on Form 8-K filed on May ~~2, 2017)~~20, 2019)

*~~10.2~~	10.1d	~~Asset Purchase~~Amendment No. 1, dated as of April 22, 2020, to the Third Amended and Restated Credit Agreement, dated as of May 17, 2019, among FMC Corporation, ~~Solutia Inc.~~certain subsidiaries of FMC Corporation party thereto, the lenders and issuing banks party thereto, and Citibank, N.A., ~~Astaris LLC, Israel Chemicals Limited and ICL Performance Products Holding Inc.,~~as Administrative Agent for such lenders. (Exhibit 10.1 to the Current Report on Form 8-K filed on April 22, 2 020 )

*10.1e	Amendment No. 2, dated as of ~~September 1, 2005 (Exhibit 10~~April 22, 2020, to the ~~Quarterly~~Term Loan Agreement, dated as of May 2, 2017, among FMC Corporation, certain subsidiaries of FMC Corporation party thereto, the lenders party thereto, and Citibank, N.A., as Administrative Agent for such lenders. (Exhibit 10.2 to the Current Report on Form ~~10-Q/A~~8-K filed on ~~November 8, 2005)~~April 22, 2020)

†*10.3	10.2	FMC Corporation Compensation Plan for Non-Employee Directors As Amended and Restated Effective ~~February 20, 2009 (Exhibit 10.4 to the Annual Report on Form 10-K filed on February 23, 2009)~~April 27, 2021

†*~~10.3.a~~	10.2.a	Non-Employee Director Restricted Stock Unit Award Agreement - Annual Grant (Exhibit ~~10.4.a~~10.3.A. to the ~~Annual~~Quarterly Report on Form ~~10-K~~10-Q filed on ~~February 23, 2009)~~May 6, 2020)

†*~~10.3.b~~	10.2.b	Non-Employee Director Restricted Stock Unit Award Agreement - ~~Annual~~ Retainer Grant (Exhibit ~~10.4.b~~10.3.B. to the ~~Annual~~Quarterly Report on Form ~~10-K~~10-Q filed on ~~February 23, 2009)~~May 6, 2020)

†*~~10.4~~	10.3	FMC Corporation Salaried Employees’ Equivalent Retirement Plan, as amended and restated effective as of January 1, 2009 (Exhibit 10.5 to the Annual Report on Form 10-K filed on February 23, 2009)

†*~~10.5~~	10.4	FMC Corporation Salaried Employees’ Equivalent Retirement Plan Grantor Trust, as amended and restated effective as July 31, 2001 (Exhibit 10.6.a to the Quarterly Report on Form 10-Q filed on November 7, 2001)

†*~~10.6~~	10.5	FMC Corporation Non-Qualified Savings and Investment Plan, as adopted by the Company on December 17, 2008 (Exhibit 10.7 to the Annual Report on Form 10-K filed on February 23, 2009)

†*~~10.7~~	10.5a	Adoption Agreement for FMC Corporation Non-Qualified Savings and Investment Plan, effective as of December 17, 2008 (Exhibit 4.2 to the Registration Statement on Form S-8 filed on December 19, 2019)

†*10.5b	Amendment to the Adoption Agreement for FMC Corporation Non-Qualified Savings and Investment Plan, effective as of January 1, 2018 (Exhibit 4.2.a to the Registration Statement on Form S-8 filed on December 19, 2019)

†*10.6	FMC Corporation Non-Qualified Savings and Investment Plan Trust, as amended and restated effective as of September 28, 2001 (Exhibit 10.7.a to the Quarterly Report on Form 10-Q filed on November 7, 2001)

~~112~~

~~Table of Contents~~




†* ~~10.7.a~~	10.6a	First Amendment to FMC Corporation Non-Qualified Savings and Investment Plan Trust between Fidelity Management Trust Company and FMC Corporation, effective as of October 1, 2003 (Exhibit 10.15a to the Annual Report on Form 10-K filed on March 11, 2004)

†* ~~10.7.b~~			10.6b	Second Amendment to FMC Corporation Non-Qualified Savings and Investment Plan Trust, effective as of January 1, 2004 (Exhibit 10.12b to the Annual Report on Form 10-K filed on March 14, 2005)

†*~~10.7.c~~			10.6c	Third Amendment to FMC Corporation Non-Qualified Savings and Investment Plan Trust between Fidelity Management Trust Company and FMC Corporation, effective as of February 14, 2005 (Exhibit 10.8.c to the Annual Report on Form 10-K filed on February 23, 2009)

†*~~10.7.d~~			10.6d	Fourth Amendment to FMC Corporation Non-Qualified Savings and Investment Plan Trust between Fidelity Management Trust Company and FMC Corporation, effective as of July 1, 2005 (Exhibit 10.8.d to the Annual Report on Form 10-K filed on February 23, 2009)

†*~~10.7.e~~			10.6e	Fifth Amendment to FMC Corporation Non-Qualified Savings and Investment Plan Trust between Fidelity Management Trust Company and FMC Corporation, effective as of April 23, 2008 (Exhibit 10.8.e to the Annual Report on Form 10-K filed on February 23, 2009)

†*~~10.7.f~~			10.6f	Sixth Amendment to FMC Corporation Non-Qualified Savings and Investment Plan Trust between Fidelity Management Trust Company and FMC Corporation, effective as of March 26, 2009 (Exhibit ~~10.7.f~~10.7f to the Annual Report on Form 10-K filed on February 28, 2017)

114

Table of Contents


†*~~10.7.g~~		10.6g	Seventh Amendment to FMC Corporation Non-Qualified Savings and Investment Plan Trust between Fidelity Management Trust Company and FMC Corporation, effective as of April 1, 2017 (Exhibit ~~10.7.g~~10.7g to the Annual Report on Form 10-K filed on February 28, 2017)

†~~10.8~~		*10.7	FMC Corporation Incentive Compensation and Stock Plan as amended and restated through April 25, 2017 (Exhibit 10.8 to the Annual Report on Form 10-K filed on February 28, 2018)

†*~~10.8a~~		10.7a	Form of Employee Restricted Stock Unit Agreement Pursuant to the FMC Corporation Incentive Compensation and Stock Plan (Exhibit ~~10.8.a~~10.8a to the Annual Report on Form 10-K filed on February 28, 2017)

†*~~10.8b~~		10.7b	Form of Nonqualified Stock Option Agreement Pursuant to the FMC Corporation Incentive Compensation and Stock Plan (Exhibit ~~10.8.b~~10.8b to the Annual Report on Form 10-K filed on February 28, 2017)

†*~~10.8c~~		10.7c	Form of Key Manager Restricted Stock Agreement Pursuant to the FMC Corporation Incentive Compensation and Stock Plan (Exhibit ~~10.8.c~~10.8c to the Annual Report on Form 10-K filed on February 28, 2017)

*~~10.8d~~		10.7d	Form of Performance-Based Restricted Stock Unit Award Agreement Pursuant to FMC Corporation Incentive Compensation and Stock Plan (Exhibit 10.8d to the Quarterly Report on Form 10-Q filed on August 2, 2017)

†*~~10.9~~		10.7e	Form of Performance-Based Restricted Stock Unit Award Agreement Pursuant to FMC Corporation Incentive Compensation and Stock Plan (Relative Total Shareholder Return Metric) (Exhibit 10.8e to the Quarterly Report on Form 10-Q filed on May 8, 2019)

†*10.7f		Form of Performance-Based Restricted Stock Unit Award Agreement Pursuant to FMC Corporation Incentive Compensation and Stock Plan (Operating Cash Flow Metric)(Exhibit 10.7f to the Annual Report on Form 10-K filed on February 2 8, 2020 )

†*10.8		FMC Corporation Executive Severance Plan, as amended and restated effective as of January 1, 2009 (Exhibit 10.10 to the Annual Report on Form 10-K filed on February 23, 2009)

†*~~10.10~~		10.9	FMC Corporation Executive Severance Grantor Trust Agreement, dated July 31, 2001 (Exhibit ~~10.10.a~~10.10a to the Quarterly Report on Form 10-Q filed on November 7, 2001)

†*10.11		10.10	Amended and Restated Executive Severance Agreement, dated November 6, 2012, between FMC Corporation and ~~Pierre Brondeau.~~ Mark Douglas

*10.11		Separation and Distribution Agreement, dated as of October 15, 2018, by and between Livent Corporation and FMC Corporation (Exhibit ~~10.2~~10.1 to ~~FMC Corporation's~~the Current Report on Form 8-K of Livent Corporation, filed on November 9, 2012) Pursuant to Instruction 2 to Item 601 of Regulation S-K, an Amended and Restated Executive Severance Agreement that is substantially identical in all material respects, except as to the parties thereto, between the Company and Mark A. Douglas was not filed.October 15, 2018, SEC File No. 1-38694) (the "Livent October 2018 Form 8-K")

†*10.12			Transition Services Agreement, dated as of October 15, 2018, by and between Livent Corporation and FMC Corporation (Exhibit 10.2 to the Livent October 2018 Form 8-K)

*10.13		Shareholders' Agreement, dated as of October 15, 2018, by and between Livent Corporation and FMC Corporation (Exhibit 10.3 to the Livent October 2018 Form 8-K)

*10.14		Tax Matters Agreement, dated as of October 15, 2018, by and between Livent Corporation and FMC Corporation (Exhibit 10.4 to the Livent October 2018 Form 8-K)

*10.15		Registration Rights Agreement, dated as of October 15, 2018, by and between Livent Corporation and FMC Corporation (Exhibit 10.5 to the Livent October 2018 Form 8-K)

†10.16		Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between Livent Corporation and FMC Corporation

*10.17		Trademark License Agreement, dated as of October 15, 2018, by and between Livent Corporation and FMC Corporation (Exhibit 10.7 to the Livent October 2018 Form 8-K)

†10.18		Executive Severance Agreement, dated ~~November 6, 2012,~~May 15, 2018, between FMC Corporation and ~~Andrea E. Utecht. (Exhibit 10.12 to FMC Corporation’s Annual Report on Form 10-K filed on February 18, 2014)~~Andrew D. Sandifer

†*10.13		10.19	~~Amended and Restated~~ Executive Severance Agreement, ~~entered into as of November 5, 2014, by and~~dated April 1, 2019, between FMC Corporation and ~~Eric Norris (Exhibit 10.13 to the Annual Report on Form 10-K filed on February 28, 2017)~~Michael Reilly

†*~~10.14~~		10.20	~~Joint Venture~~Letter Agreement dated April 27, 2020 between FMC Corporation and ~~Solutia Inc., made as of April 29, 1999~~Pierre Brondeau (Exhibit ~~2.I~~10.1 to ~~Solutia’s~~the Current Report on Form 8-K filed on April ~~27, 2000)~~30, 2020)

*10.14.a	~~First Amendment to Joint Venture Agreement between FMC Corporation and Solutia Inc., effective as of December 29, 1999 (Exhibit 2.II to Solutia’s Current Report on Form 8-K filed on April 27, 2000)~~

*10.14.b	~~Second Amendment to Joint Venture Agreement between FMC Corporation and Solutia Inc., effective as of February 9, 2000 (Exhibit 2.III to Solutia’s Current Report on Form 8-K filed on April 27, 2000)~~

~~113~~

~~Table of Contents~~



*10.14.c21		~~Third Amendment to Joint Venture Agreement between FMC Corporation and Solutia Inc., effective as of March 31, 2000 (Exhibit 2.IV to Solutia’s Current Report on Form 8-K filed on April 27, 2000)~~

*10.14.d	~~Fourth Amendment to Joint Venture Agreement between FMC Corporation and Solutia Inc., dated November 4, 2005 (Exhibit 10 to FMC Corporation’s Current Report on Form 8-K filed on November 9, 2005)~~

*10.15	Separation and Distribution Agreement by and between FMC Corporation and FMC Technologies, Inc., dated as of May 31, 2001 (Exhibit 2.1 to Form S-1/A for FMC Technologies, Inc. (Registration No. 333-55920) filed on June 6, 2001)

~~†*10.16~~	~~Letter Agreement dated October 23, 2009 between FMC Corporation and Pierre Brondeau (Exhibit 10.18 to FMC Corporation’s Annual Report on Form 10-K filed on February 22, 2010)~~

~~†*10.16.a~~	Amendment to October 23, 2009 Letter Agreement, dated November 6, 2012, between FMC Corporation and Pierre Brondeau. (Exhibit 10.1 to FMC Corporation’s Current Report on Form 8-K filed on November 9, 2012)

~~†*10.17~~	~~Executive Severance Agreement, dated November 6, 2012, between FMC Corporation and Paul W. Graves. (Exhibit 10.3 to FMC Corporation’s Current Report on Form 8-K filed on November 9, 2012)~~

~~10.18~~	~~Retention Letter, dated April 4, 2017, between FMC Corporation and Eric Norris~~

12	~~Computation of Ratios of Earnings to Fixed Charges~~

21	FMC Corporation List of Significant Subsidiaries

23.1		Consent of KPMG LLP

31.1		Chief Executive Officer Certification

31.2		Chief Financial Officer Certification

115

Table of Contents


32.1			Chief Executive Officer Certification of Annual Report

32.2			Chief Financial Officer Certification of Annual Report

101			Interactive Data File

* Incorporated by reference

† Management contract or compensatory plan or arrangement

~~114~~

~~Table of Contents~~


~~ITEM 16.~~	~~FORM 10-K SUMMARY~~

ITEM 16. FORM 10-K SUMMARY

Optional disclosure, not included in this Report.

~~115~~

116

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

FMC CORPORATION

(Registrant)



By:			/S/ P~~AUL~~ ~~W. GRAVES~~ ANDREW D. SANDIFER
			~~Paul W. Graves~~Andrew D. Sandifer Executive Vice President and Chief Financial Officer

Date: February ~~28, 2018~~25, 2021

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated.



Signature			Title		Date
/S/ P~~AUL~~ ~~W. GRAVES~~ANDREW D. SANDIFER ~~Paul W. Graves~~Andrew D. Sandifer			Executive Vice President and Chief Financial Officer		February ~~28, 2018~~25, 2021

/S/ NICHOLAS L. PFEIFFER Nicholas L. Pfeiffer			Vice President, ~~Corporate Controller and~~ Chief Accounting Officer, and Corporate Controller		February ~~28, 2018~~25, 2021

/S/ PIERRE R. BRONDEAU Pierre R. Brondeau			Executive Chairman		February 25, 2021

/S/ MARK A. DOUGLAS Mark A. Douglas			President, Chief Executive Officer, and ~~Chairman of the Board~~ Director		February ~~28, 2018~~25, 2021

~~/S/ G. PETER~~ ~~D’ALOIA~~ ~~G. Peter D’Aloia~~			~~Director~~	~~February 28, 2018~~

/S/ EDUARDO E. CORDEIRO Eduardo E. Cordeiro	Director			February ~~28, 2018~~25, 2021

/S/ CAROL ANTHONY ("JOHN") DAVIDSON Carol Anthony ("John") Davidson			Director		February 25, 2021

/S/ C. SCOTT GREER C. Scott Greer			Director		February ~~28, 2018~~25, 2021

/S/K'LYNNE JOHNSON K'Lynne Johnson			Director		February 25, 2021

/S/ DIRK A. KEMPTHORNE Dirk A. Kempthorne			Director		February ~~28, 2018~~25, 2021

/S/ PAUL J. NORRIS Paul J. Norris			Director		February ~~28, 2018~~25, 2021

/S/ MARGARETHØVRUM Margareth Øvrum			Director		February 25, 2021

/S/ ROBERT C. PALLASH Robert C. Pallash			Director		February ~~28, 2018~~25, 2021

/S/ VINCENT R. VOLPE, JR. Vincent R. Volpe, Jr.			Director		February ~~28, 2018~~

~~/S/~~W~~ILLIAM~~ ~~H. POWELL~~ ~~William H. Powell~~	~~Director~~	~~February 28, 2018~~

~~/S/~~ ~~MARGARETH OEVRUM~~ ~~Margareth Oevrum~~	~~Director~~	~~February 28, 2018~~

~~/S/K'LYNNE~~ J~~OHNSON~~ ~~K'Lynne Johnson~~	~~Director~~	~~February 28, 2018~~25, 2021

~~116~~

117



Delaware			94-0479804
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)

2929 Walnut Street ~~Philadelphia, Pennsylvania~~	Philadelphia	Pennsylvania	19104
(Address of principal executive offices)			(Zip Code)



DOCUMENT						FORM 10-K REFERENCE
Portions of Proxy Statement for ~~2018~~2021 Annual Meeting of Stockholders						Part III


		Page
PART I
Item 1. Business		4
Item 1A. Risk Factors		12
Item 1B. Unresolved Staff Comments		17
Item 2. Properties		17
Item 3. Legal Proceedings		17
Item 4. Mine Safety Disclosures		18
Item 4A. Information about our Executive Officers		18

PART II

		~~Page~~
~~PART I~~
~~Item 1. Business~~	4
~~Item 1A. Risk Factors~~	10
~~Item 1B. Unresolved Staff Comments~~	13
~~Item 2. Properties~~	13
~~Item 3. Legal Proceedings~~	14
~~Item 4. Mine Safety Disclosures~~	14
~~Item 4A. Executive Officers of the Registrant~~	14

~~PART II~~

Item 5. Market for the Registrant’s Common Equity, Related Stockholders Matters and Issuer Purchases of Equity Securities	1419
Item 6. Selected Financial Data		1621
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations		1823
Item 7A. Quantitative and Qualitative Disclosures about Market Risk		3846
Item 8. Financial Statements and Supplementary Data		3947
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure		~~108~~111
Item 9A. Controls and Procedures		~~108~~111
Item 9B. Other Information		~~109~~111

PART III

Item 10. Directors, Executive Officers and Corporate Governance		~~110~~112
Item 11. Executive Compensation		~~110~~112
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters		~~110~~112
Item 13. Certain Relationships and Related Transactions, and Director Independence		~~110~~112
Item 14. Principal Accountant Fees and Services		~~111~~112

PART IV

Item 15. Exhibits and Financial Statement Schedules		~~111~~113
Item 16. Form 10-K Summary		~~115~~116
Signatures		~~116~~117



~~Segment~~Product			~~Product~~	Raw Materials	Uses
~~FMC Agricultural Solutions~~Insecticides			~~Insecticides~~	Synthetic and biological chemical intermediates	Protection of crops, including soybean, corn, fruits and vegetables, cotton, sugarcane, rice, and cereals, from insects and for non-agricultural applications including pest control for home, garden and other specialty markets
Herbicides			~~Herbicides~~	Synthetic and biological chemical intermediates	Protection of crops, including cotton, sugarcane, rice, corn, soybeans, cereals, fruits and vegetables from weed growth and for non-agricultural applications including turf and roadsides
Fungicides			~~Fungicides~~	Synthetic and biological chemical intermediates	Protection of crops, including cereals, fruits and vegetables from fungal disease

~~FMC Lithium~~	~~Lithium~~	~~Various lithium products~~	~~Batteries, polymers, pharmaceuticals, greases and lubricants, glass and ceramics and other industrial uses~~



	2017								2016
Common stock prices:	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		First Quarter		Second Quarter		Third Quarter		Fourth Quarter
High	$	72.04	$	77.38	$	93.44	$	96.02	$	42.03	$	50.57	$	49.19	$	60.00
Low	56.42		69.81		72.65		87.56		32.24		36.72		43.26		45.77



X☒			Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



☐			Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Numbers of active Granted Patents by type*: Chlorantraniliprole and Cyantraniliprole, as of December 31, 2020
	United States	Foreign
Active Ingredients	21	252
Intermediates and Methods of Manufacturing	23	254
Formulations/Mixtures/Applications	9	338
Total	53	844


Remaining Life of Granted Patents: Chlorantraniliprole and Cyantraniliprole, as of December 31, 2020
	United States	Foreign
Through December 31, 2025	36	550
2026 - 2030	15	266
2031 - 2036	2	28
Total	53	844



	Year Ended December 31,
(in Millions)	2017		2016		2015
FMC Agricultural Solutions	$	138.4	$	131.4	$	132.4
FMC Lithium	3.1		3.1		3.5
Total	$	141.5	$	134.5	$	135.9


	North America	Latin America	Europe, Middle East and Africa	Asia	Total


Total	5	2	6	12	25



	North America	Latin America	Europe, Middle East and Africa	Asia- Pacific	Total
FMC Agricultural Solutions	4	3	6	13	26
FMC Lithium	1	2	1	3	7
Total	5	5	7	16	33


~~ITEM 5.~~	~~MARKET FOR THE REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDERS MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES~~


EQ Shareowner Services
1110 Centre Pointe Curve, Suite 101			or	P.O. Box 64874
Mendota Heights, MN 55120-4100				St. Paul, MN 55164-0854

~~Wells Fargo Bank, N.A.~~Phone: 1-800-468-9716
~~Shareowner Services~~
~~1110 Centre Pointe Curve, Suite 101~~	or	~~P.O. Box 64854~~
~~Mendota Heights, MN 55120-4100~~		~~St. Paul, MN 55164-0854~~

~~Phone: 1-800-468-9716~~
(651-450-4064 local and outside the U.S.)
~~www.wellsfargo.com/shareownerservices~~https://equiniti.com/us/



	2012		2013		2014		2015		2016		2017
FMC Corporation	$	100.00	$	129.87	$	99.18	$	69.20	$	101.19	$	170.54
S&P 500 Index	100.00		132.04		149.89		151.94		169.82		206.62
S&P 500 Chemicals Index	100.00		131.43		145.42		139.42		153.34		194.02


~~ITEM 1A.~~	ITEM 1A. RISK FACTORS


~~ITEM 1B.~~	~~UNRESOLVED STAFF COMMENTS~~


~~ITEM 2.~~	~~PROPERTIES~~


~~ITEM 3.~~	ITEM 3. LEGAL PROCEEDINGS


				Publicly Announced Program
Period	Total Number of Shares Purchased (1)	Average Price Paid Per Share		Total Number of Shares Purchased	Total Dollar Amount Purchased		Maximum Dollar Value of Shares that May Yet be Purchased
October	187,511	$	107.18	186,581	$	19,999,977	$	580,000,643
November	224,837	113.36		210,000	23,818,775		556,181,868
December	53,983	118.91		51,957	6,181,212		550,000,656
Total	466,331	$	111.52	448,538	$	49,999,964



				Publicly Announced Program ⁽¹⁾
Period	Total Number of Shares Purchased ⁽²⁾	Average Price Paid Per Share		Total Number of Shares Purchased	Total Dollar Amount Purchased		Maximum Dollar Value of Shares that May Yet be Purchased
October 1-31, 2017	340	$	93.14	—	$	—	$	238,779,078
November 1-30, 2017	118	93.68		—	—		238,779,078
December 1-31, 2017	9,274	93.03		—	—		238,779,078
Total	9,732	$	93.05	—	$	—	$	238,779,078


~~(1)~~	This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors.


~~(2)~~	~~We also reacquire shares from time to time from employees in connections with vesting, exercise, and forfeiture of awards under our equity compensation plans.~~


	Year Ended December 31,
(in Millions, except per share data)	2020		2019		2018		2017		2016
Income Statement Data:
Revenue	$	4,642.1	$	4,609.8	$	4,285.3	$	2,531.2	$	2,274.8
Income from continuing operations before equity in (earnings) loss of affiliates, non-operating pension and postretirement charges (income), interest expense, net and income taxes	902.2		821.6		740.9		158.5		197.8
Income (loss) from continuing operations before income taxes	729.8		655.0		608.4		95.8		111.6
Income (loss) from continuing operations	$	578.9	$	543.5	$	537.6	$	(133.1)	$	73.4
Discontinued operations, net of income taxes (1)	(28.3)		(63.3)		(26.1)		671.5		138.3
Net income (loss)	$	550.6	$	480.2	$	511.5	$	538.4	$	211.7
Less: Net income (loss) attributable to noncontrolling interest	(0.9)		2.8		9.4		2.6		2.6
Net income (loss) attributable to FMC stockholders	$	551.5	$	477.4	$	502.1	$	535.8	$	209.1
Amounts attributable to FMC stockholders:
Continuing operations, net of income taxes	$	579.8	$	540.7	$	531.4	$	(135.7)	$	71.1
Discontinued operations, net of income taxes	(28.3)		(63.3)		(29.3)		671.5		138.0
Net income (loss)	$	551.5	$	477.4	$	502.1	$	535.8	$	209.1
Basic earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	4.46	$	4.12	$	3.94	$	(1.01)	$	0.53
Discontinued operations	(0.22)		(0.48)		(0.22)		5.00		1.03
Net income (loss)	$	4.24	$	3.64	$	3.72	$	3.99	$	1.56
Diluted earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	4.44	$	4.10	$	3.91	$	(1.01)	$	0.53
Discontinued operations	(0.22)		(0.48)		(0.22)		5.00		1.03
Net income (loss)	$	4.22	$	3.62	$	3.69	$	3.99	$	1.56

Balance Sheet Data:
Total assets	$	10,186.4	$	9,872.7	$	9,974.3	$	9,206.3	$	6,139.3
Long-term debt	3,023.1		3,113.9		2,531.0		3,094.2		1,801.2

Other Data:
Cash dividends declared per share	$	1.80	$	1.64	$	0.90	$	0.66	$	0.66



	Year Ended December 31,
(in Millions, except per share data and ratios)	2017			2016		2015			2014		2013
Income Statement Data:
Revenue	$	2,878.6		$	2,538.9	$	2,491.0		$	2,430.5	$	2,368.7
Income (loss) from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes	259.8			243.2		(146.5		)	246.0		380.6
Income (loss) from continuing operations before income taxes	180.8			180.8		(207.4		)	206.8		353.8
Income (loss) from continuing operations	(83.3		)	130.7		(212.6		)	190.4		342.4
Discontinued operations, net of income taxes ⁽¹⁾	621.7			81.0		711.1			131.7		(34.4		)
Net income	$	538.4		$	211.7	$	498.5		$	322.1	$	308.0
Less: Net income attributable to noncontrolling interest	2.6			2.6		9.5			14.6		14.1
Net income attributable to FMC stockholders	$	535.8		$	209.1	$	489.0		$	307.5	$	293.9
Amounts attributable to FMC stockholders:
Continuing operations, net of income taxes	$	(85.9	)	$	128.4	$	(222.0	)	$	180.6	$	336.0
Discontinued operations, net of income taxes	621.7			80.7		711.0			126.9		(42.1		)
Net income	$	535.8		$	209.1	$	489.0		$	307.5	$	293.9
Basic earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	(0.64	)	$	0.96	$	(1.66	)	$	1.35	$	2.48
Discontinued operations	4.63			0.60		5.32			0.95		(0.32		)
Net income	$	3.99		$	1.56	$	3.66		$	2.30	$	2.16
Diluted earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	(0.64	)	$	0.96	$	(1.66	)	$	1.34	$	2.47
Discontinued operations	4.63			0.60		5.32			0.95		(0.31		)
Net income	$	3.99		$	1.56	$	3.66		$	2.29	$	2.16
Balance Sheet Data:
Total assets	$	9,206.3		$	6,139.3	$	6,325.9		$	5,326.0	$	5,224.6
Long-term debt	3,094.2			1,801.2		2,037.8			1,140.9		1,178.2
Other Data:
Ratio of earnings (loss) to fixed charges ⁽²⁾	3.0			3.4		(1.9		)	5.5		11.2
Cash dividends declared per share	$	0.660		$	0.660	$	0.660		$	0.600	$	0.540


~~ITEM 7.~~	~~MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS~~



SEGMENT RESULTS RECONCILIATION
(in Millions)	Year Ended December 31,
(in Millions)	2017			2016			2015
Revenue
FMC Agricultural Solutions	$	2,531.2		$	2,274.8		$	2,252.9
FMC Lithium	347.4			264.1			238.1
Total	$	2,878.6		$	2,538.9		$	2,491.0
Income (loss) from continuing operations before income taxes
FMC Agricultural Solutions	$	485.6		$	399.9		$	363.9
FMC Lithium	126.7			70.2			23.0
Segment operating profit	$	612.3		$	470.1		$	386.9
Corporate and other	(102.4		)	(84.6		)	(63.0		)
Operating profit before the items listed below	$	509.9		$	385.5		$	323.9
Interest expense, net	(79.1		)	(62.9		)	(60.9		)
Restructuring and other (charges) income ⁽¹⁾	(81.4		)	(95.0		)	(150.3		)
Non-operating pension and postretirement (charges) income ⁽²⁾	(18.2		)	(23.4		)	(29.8		)
Acquisition related charges⁽³⁾	(150.4		)	(23.4		)	(290.3		)
(Provision) benefit for income taxes	(264.1		)	(50.1		)	(5.2		)
Discontinued operations, net of income taxes	621.7			81.0			711.1
Net (income) loss attributable to noncontrolling interests	(2.6		)	(2.6		)	(9.5		)
Net income attributable to FMC stockholders	$	535.8		$	209.1		$	489.0


~~(1)~~	~~See Note 7 to the consolidated financial statements included within this Form 10-K for details of restructuring and other (charges) income by segment:~~


~~(1)~~	The income tax expense (benefit) on Corporate special charges (income) is determined using the applicable rates in the taxing jurisdictions in which the Corporate special charge or income occurred and includes both current and deferred income tax expense (benefit) based on the nature of the non-GAAP performance measure.


	Twelve Months Ended December 31, 2020 vs. 2019
Total Revenue Change (GAAP)	1	%
Less: Foreign Currency Impact	(6%)
Organic Revenue Change (Non-GAAP)	7	%


Total Revenue by Region
	Year Ended December 31,
(in Millions)	2020		2019		2018
North America	$	1,032.5	$	1,121.1	$	1,090.8
Latin America	1,456.5		1,441.7		1,210.1
Europe, Middle East and Africa (EMEA)	1,046.3		1,001.8		966.0
Asia	1,106.8		1,045.2		1,018.4
Total	$	4,642.1	$	4,609.8	$	4,285.3



FMC Agricultural Solutions Pro Forma Financial Results
	Twelve Months Ended December 31,
(in Millions)	2016		2015
Revenue
Revenue, FMC Agricultural Solutions, as reported ⁽¹⁾	$	2,274.8	$	2,252.9
Revenue, Cheminova, pro forma ⁽²⁾	—		362.0
Pro Forma Combined, Revenue ⁽³⁾	$	2,274.8	$	2,614.9
Operating Profit
Operating Profit, FMC Agricultural Solutions, as reported ⁽¹⁾	$	399.9	$	363.9
Operating Profit, Cheminova, pro forma ⁽²⁾	—		19.9
Pro Forma Combined, Operating Profit ⁽³⁾	$	399.9	$	383.8


~~(1)~~	~~As reported amounts are the results of operations of FMC Agricultural Solutions, including the results of the Cheminova acquisition from April 21, 2015 onward.~~


~~(3)~~	The pro forma combined amounts are not necessarily indicative of what the results would have been had we acquired Cheminova on January 1, 2015 or indicative of future results. For the twelve months ended December 31, 2016, pro forma results and actual results are the same.



FMC Agricultural Solutions Combined Revenue by Region
	Twelve Months Ended December 31,
(in Millions)	2017		2016		2015 ⁽¹⁾
Europe, Middle East and Africa (EMEA) ^{(2) (6)}	$	523.8	$	516.3	$	585.7
North America ^{(3) (7)}	626.7		557.8		595.2
Latin America ^{(4) (8)}	866.6		758.8		965.3
Asia^{(5) (9)}	514.1		441.9		468.7
Total	$	2,531.2	$	2,274.8	$	2,614.9


~~(1)~~	Combined revenue by region for the twelve months ended December 31, 2015 includes the results of Cheminova assuming the acquisition occurred on January 1, 2015. The pro forma combined revenue by region amounts are not necessarily indicative of what the results would have been had we acquired Cheminova on January 1, 2015 or indicative of future results.


~~(2)~~	Increase in the twelve months ended December 31, 2017 was driven by strong sales in France as we moved to direct market access. Additionally, favorable pricing and new product launches in cereal herbicides and fungicides contributed to the increase. These increases were partially offset by a late start to the season in Northwestern Europe in the first quarter of 2017.


~~(3)~~	~~Increase in the twelve months ended December 31, 2017 was driven by strong demand for both pre- and post-emergent herbicides, as well as foliar insecticides.~~


~~(4)~~	Increase for the twelve months ended December 31, 2017 was driven by growth in soybean applications in Brazil, as well as increased insecticide volumes in Argentina and Mexico. Additionally, successful product launches contributed to the revenue increase.